Organised by the Society for Laboratory Automation and Screening (SLAS), SLAS Europe currently is taking place in Hamburg from 20–22 May. As part of a special series, European Biotechnology Magazine is profiling twelve of the most innovative exhibiting SMEs supported under the SLAS AveNew programme. Among them is US-based ThirdLaw Molecular Inc.
EU set to improve investment for biotech start-ups and scale-ups
Latest NewsThe European Commission has promised to create a new public-private fund to bridge the ‘valley of death’ phase for technology companies facing expansion. In addition, the EU wants to reduce its lag in the number of technology unicorns compared to the United States and China with a start-up and scale-up strategy.
Norwegian Mycelium AS bags €1.25m to scale mycoprotein production
Latest NewsFoodtech startup Norwegian Mycelium A/S has raised €1.25m in a financing round led by Nippon Beet Sugar Manufacturing Co., Ltd. (Nitten), Japan’s largest beet sugar producer, to scale-up its mycoprotein platform.
Vetter Once Again Named Best Managed Company
Sponsored PublicationsThe award jury recognizes strategic and sustainable corporate management.
Reproducible nanopore sequencing to be commercialised from 2026
Latest NewsFor nearly two decades, Roche AG has been searching for a next-generation sequencing method in personalised medicine to overcome the limitations of short read lengths in existing sequencing technologies. Following beta testing, the company plans to launch its new Sequencing by Expansion (SBX) technology commercially next year.
Unlocking the treasure trove
BackgroundThe Hamburg-based company Indivumed has repositioned itself, sending a clear message with a recent change in leadership: A new chapter is beginning with the focus on discovering and developing novel therapeutic targets for innovative cancer therapies. |transkript spoke with Prof. Dr. Hartmut Juhl and Dr. Matthias Evers.
C4X Discovery bags milestone for IL-17A blocker from Sanofi
Latest NewsC4X Discovery Holdings Ltd has received a €8m milestone payment from the French pharmaceutical company Sanofi for its preclinical IL-17A inhibitor. This payment is based on a licence agreement from 2021, under which the British company could receive up to €414m, including royalties.
New way to target mitochondrial diseases
Latest NewsPharmacologists at the University of Göttingen, Germany, have reported a simple way to target and silence individual mitochondrial mRNAs in vivo.
Biopharma transformation: leading drug discovery start-ups of 2025
Associations, Latest NewsBritish company Wildcat Laboratory Solutions Ltd and Hamburg-based mo:re GmbH have received the New Product Award from the Society for Laboratory Automation and Screening (SLAS) in recognition of new technologies with potential to drive industry transformation. The award for the most promising start-up was conferred upon Swiss firm Oryl Photonics SA.
Countdown to SLAS Europe: ThirdLaw Molecular Inc.
Associations, Latest NewsOrganised by the Society for Laboratory Automation and Screening (SLAS), SLAS Europe currently is taking place in Hamburg from 20–22 May. As part of a special series, European Biotechnology Magazine is profiling twelve of the most innovative exhibiting SMEs supported under the SLAS AveNew programme. Among them is US-based ThirdLaw Molecular Inc.
BioNTech Secures £129m UK Backing
Latest NewsBioNTech is set to open a research centre for cancer therapy in the United Kingdom, much to the delight of the British government, which is helping pave the way with a substantial financial boost.